HIGHLIGHTS
- who: Peter R. Feldman from the Medical University of South Carolina, United States have published the Article: Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium, in the Journal: (JOURNAL) of 13/07/2022
- what: The authors report herein the pertinent similarities and differences in outcomes of the trials between women and men.
SUMMARY
Secondary outcomes: Response rate, changes in vellus hair (VH) density, TH/VH ratio, hair diameter, growth, and shedding rate. Green ovals represent increases of hair density, and red ovals are reductions. (a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.